Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


23.10.2017

3 Acta Neuropathol
4 AJNR Am J Neuroradiol
1 Am J Clin Oncol
1 BMC Cancer
1 Brain
1 Cancer
2 Childs Nerv Syst
2 Clin Neuropathol
2 Int J Cancer
1 J Natl Cancer Inst
3 J Neurooncol
1 J Neuropathol Exp Neurol
1 J Neurosurg
11 Neuro Oncol
5 Neurosurgery
1 Pediatr Hematol Oncol
5 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol

  1. BEYER U, Brand F, Martens H, Weder J, et al
    Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis.
    Acta Neuropathol. 2017 Oct 13. doi: 10.1007/s00401-017-1774.
    PubMed     Text format     Abstract available

  2. KORSHUNOV A, Chavez L, Northcott PA, Sharma T, et al
    DNA-methylation profiling discloses significant advantages over NanoString method for molecular classification of medulloblastoma.
    Acta Neuropathol. 2017 Oct 13. doi: 10.1007/s00401-017-1776.
    PubMed     Text format    

  3. WIJNENGA MMJ, Dubbink HJ, French PJ, Synhaeve NE, et al
    Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification.
    Acta Neuropathol. 2017 Oct 19. doi: 10.1007/s00401-017-1781.
    PubMed     Text format    


    AJNR Am J Neuroradiol

  4. ZHANG LH, Yuan HS
    Imaging Appearances and Pathologic Characteristics of Spinal Epidural Meningioma.
    AJNR Am J Neuroradiol. 2017 Oct 19. doi: 10.3174/ajnr.A5414.
    PubMed     Text format     Abstract available

  5. IVANIDZE J, Charalel RA, Shuryak I, Brenner D, et al
    Effects of Radiation Exposure on the Cost-Effectiveness of CT Angiography and Perfusion Imaging in Aneurysmal Subarachnoid Hemorrhage.
    AJNR Am J Neuroradiol. 2017;38:462-468.
    PubMed     Text format     Abstract available

  6. MCGUINNESS BJ, Morrison JP, Brew SK, Moriarty MW, et al
    Benign Enhancing Foramen Magnum Lesions: Clinical Report of a Newly Recognized Entity.
    AJNR Am J Neuroradiol. 2017;38:721-725.
    PubMed     Text format     Abstract available

  7. JOHNSON DR, Diehn FE, Giannini C, Jenkins RB, et al
    Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI.
    AJNR Am J Neuroradiol. 2017;38:678-684.
    PubMed     Text format     Abstract available


    Am J Clin Oncol

  8. MOKHTECH M, Morris CG, Indelicato DJ, Rutenberg MS, et al
    Patterns of Failure in Patients With Adult Medulloblastoma Presenting Without Extraneural Metastasis.
    Am J Clin Oncol. 2017 Oct 17. doi: 10.1097/COC.0000000000000407.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. ANGELINO G, De Pasquale MD, De Sio L, Serra A, et al
    NRAS(Q61K) mutated primary leptomeningeal melanoma in a child: case presentation and discussion on clinical and diagnostic implications.
    BMC Cancer. 2016;16:512.
    PubMed     Text format     Abstract available


    Brain

  10. HARFORD-WRIGHT E, Andre-Gregoire G, Jacobs KA, Treps L, et al
    Pharmacological targeting of apelin impairs glioblastoma growth.
    Brain. 2017 Oct 3. doi: 10.1093.
    PubMed     Text format     Abstract available


    Cancer

  11. PRINTZ C
    Device rapidly measures cell growth and can help determine drug resistance in cancer.
    Cancer. 2017;123:10-11.
    PubMed     Text format    


    Childs Nerv Syst

  12. DE OLIVEIRA RS, Viana DC, Augusto LP, Santos MV, et al
    The supraorbital eyebrow approach for removal of craniopharyngioma in children: a case series.
    Childs Nerv Syst. 2017 Oct 16. doi: 10.1007/s00381-017-3615.
    PubMed     Text format     Abstract available

  13. RASHID A, Ram AN, Kates WR, Redmond KJ, et al
    Correction to: A prospective study of corpus callosum regional volumes and neurocognitive outcomes following cranial radiation for pediatric brain tumors.
    Childs Nerv Syst. 2017 Oct 14. doi: 10.1007/s00381-017-3607.
    PubMed     Text format     Abstract available


    Clin Neuropathol

  14. JOHNSON KJ, Schwartzbaum J, Kruchko C, Scheurer ME, et al
    Brain tumor epidemiology in the era of precision medicine: The 2017 Brain Tumor Epidemiology Consortium meeting report.
    Clin Neuropathol. 2017 Oct 16. doi: 10.5414/NP301066.
    PubMed     Text format     Abstract available

  15. LESKE H, Brandal P, Rushing EJ, Niehusmann P, et al
    IDH-mutant giant cell glioblastoma: A neglected tumor variant?
    Clin Neuropathol. 2017 Oct 16. doi: 10.5414/NP301054.
    PubMed     Text format    


    Int J Cancer

  16. MURRAY MJ, Bailey S, Heinemann K, Mann J, et al
    Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.
    Int J Cancer. 2017 Apr 30. doi: 10.1002/ijc.30755.
    PubMed     Text format     Abstract available

  17. CAO M, Mao J, Duan X, Lu L, et al
    In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31113.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  18. VERMA V, Simone CB 2nd, Mishra MV
    Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


    J Neurooncol

  19. SENDERS JT, Goldhaber NH, Cote DJ, Muskens IS, et al
    Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis.
    J Neurooncol. 2017 Oct 16. doi: 10.1007/s11060-017-2631.
    PubMed     Text format     Abstract available

  20. RUDA R, Pellerino A, Franchino F, Bertolotti C, et al
    Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study.
    J Neurooncol. 2017 Oct 13. doi: 10.1007/s11060-017-2628.
    PubMed     Text format     Abstract available

  21. MIYAI M, Tomita H, Soeda A, Yano H, et al
    Current trends in mouse models of glioblastoma.
    J Neurooncol. 2017 Oct 20. doi: 10.1007/s11060-017-2626.
    PubMed     Text format     Abstract available


    J Neuropathol Exp Neurol

  22. FOO ASC, Tan DTM, Tan CL, Sahm F, et al
    Report of a Novel Case of Anaplastic Olfactory Groove Meningioma and Its Methylation Subtype.
    J Neuropathol Exp Neurol. 2017 Oct 16. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Neurosurg

  23. FIGUEROA JM, Carter BS
    Detection of glioblastoma in biofluids.
    J Neurosurg. 2017 Oct 20:1-7. doi: 10.3171/2017.3.JNS162280.
    PubMed     Text format     Abstract available


    Neuro Oncol

  24. ESKILSSON E, Rosland GV, Solecki G, Wang Q, et al
    EGFR heterogeneity and implications for therapeutic intervention in glioblastoma.
    Neuro Oncol. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format     Abstract available

  25. UNTERRAINER M, Niyazi M, Ruf V, Bartenstein P, et al
    The endothelial prostate-specific membrane antigen is highly expressed in gliosarcoma and visualized by [68Ga]-PSMA-11 PET: a theranostic outlook for brain tumor patients?
    Neuro Oncol. 2017 Oct 17. doi: 10.1093.
    PubMed     Text format    

  26. FORST D, Adams E, Nipp R, Martin A, et al
    Hospice Utilization in Patients with Malignant Gliomas.
    Neuro Oncol. 2017 Oct 16. doi: 10.1093.
    PubMed     Text format     Abstract available

  27. OLMEZ I, Love S, Xiao A, Manigat L, et al
    Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha.
    Neuro Oncol. 2017 Jun 29. doi: 10.1093.
    PubMed     Text format     Abstract available

  28. ELLINGSON BM, Wen PY, Cloughesy TF
    Evidence and Context of Use for Contrast Enhancement as a Surrogate of Disease Burden and Treatment Response in Malignant Glioma.
    Neuro Oncol. 2017 Oct 12. doi: 10.1093.
    PubMed     Text format     Abstract available

  29. SAHM F, Wick A
    ID(H)entifying checkpoint inhibitor candidates among diffuse glioma.
    Neuro Oncol. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format    

  30. MALTA TM, de Souza CF, Sabedot TS, Silva TC, et al
    Glioma CpG Island Methylator Phenotype (G-CIMP): Biological and Clinical Implications.
    Neuro Oncol. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available

  31. KICKINGEREDER P, Neuberger U, Bonekamp D, Piechotta PL, et al
    Radiomic subtyping improves disease stratification beyond key molecular, clinical and standard imaging characteristics in patients with glioblastoma.
    Neuro Oncol. 2017 Sep 28. doi: 10.1093.
    PubMed     Text format     Abstract available

  32. KAUR S, Ramdzan ZM, Guiot MC, Li L, et al
    CUX1 Stimulates APE1 Enzymatic Activity and Increases the Resistance of Glioblastoma Cells to the Mono-Alkylating Agent, Temozolomide.
    Neuro Oncol. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available

  33. CLOUGHESY TF, Drappatz J, de Groot J, Prados MD, et al
    Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy.
    Neuro Oncol. 2017 Oct 3. doi: 10.1093.
    PubMed     Text format     Abstract available

  34. RUIZ VY, Praska CE, Armstrong G, Kollmeyer TM, et al
    Molecular Subtyping of Tumors from Patients with Familial Glioma.
    Neuro Oncol. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neurosurgery

  35. BUTTRICK S, Komotar RJ
    Introduction for Laser Interstitial Thermal Therapy (LITT) in Neurosurgery Supplement.
    Neurosurgery. 2016;79 Suppl 1:S1-S2.
    PubMed     Text format     Abstract available

  36. SLOAN AE, Fung H, Reese J, Rogers LR, et al
    141 Phase I Trial of Genetically Modified Hematopoietic Progenitor Cells Facilitate Bone Marrow Chemoprotection and Enabling TMZ/O6BG Dose Escalation Resulting in Improved Survival.
    Neurosurgery. 2016;63 Suppl 1:157.
    PubMed     Text format     Abstract available

  37. SMITH CJ, Myers CS, Chapple KM, Smith KA, et al
    Long-Term Follow-up of 25 Cases of Biopsy-Proven Radiation Necrosis or Post-Radiation Treatment Effect Treated With Magnetic Resonance-Guided Laser Interstitial Thermal Therapy.
    Neurosurgery. 2016;79 Suppl 1:S59-S72.
    PubMed     Text format     Abstract available

  38. MASSEY SC, Johnston SK, Canoll PD, Bruce JN, et al
    Letter: Surgical Decision Making From Image-Based Biophysical Modeling of Glioblastoma: Not Ready for Primetime.
    Neurosurgery. 2017 Sep 29. doi: 10.1093.
    PubMed     Text format    

  39. VENTEICHER AS, Tirosh I, Hebert C, Escalante L, et al
    142 Genetic and Nongenetic Determinants of Cellular Architecture in IDH1-Mutant Oligodendrogliomas and Astrocytomas Using Single-Cell Transcriptome Analysis.
    Neurosurgery. 2016;63 Suppl 1:158.
    PubMed     Text format     Abstract available


    Pediatr Hematol Oncol

  40. BAVLE A, Jones J, Lin FY, Malphrus A, et al
    Dramatic clinical and radiographic response to BRAF inhibition in a patient with progressive disseminated optic pathway glioma refractory to MEK inhibition.
    Pediatr Hematol Oncol. 2017 Oct 17:1-6. doi: 10.1080/08880018.2017.1360971.
    PubMed     Text format     Abstract available


    PLoS One

  41. MELEIS AM, Mahtabfar A, Danish S, Foty RA, et al
    Dexamethasone-mediated inhibition of Glioblastoma neurosphere dispersal in an ex vivo organotypic neural assay.
    PLoS One. 2017;12:e0186483.
    PubMed     Text format     Abstract available

  42. HSU CY, Ho HL, Lin SC, Ho TD, et al
    The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.
    PLoS One. 2017;12:e0186430.
    PubMed     Text format     Abstract available

  43. KIM SW, Shin HJ, Hwang JH, Shin JS, et al
    Image similarity evaluation of the bulk-density-assigned synthetic CT derived from MRI of intracranial regions for radiation treatment.
    PLoS One. 2017;12:e0185082.
    PubMed     Text format     Abstract available

  44. LEE JY, Park JE, Kim HS, Kim SO, et al
    Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients.
    PLoS One. 2017;12:e0183916.
    PubMed     Text format     Abstract available

  45. PRABHU VV, Lulla AR, Madhukar NS, Ralff MD, et al
    Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
    PLoS One. 2017;12:e0180541.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: